Federal contractor · public award history

THE INSTITUTE FOR CANCER RESEARCH

UEIFF1XVJMDYVR1CAGE1RAF4SAM ActivePHILADELPHIA, PENNSYLVANIA

Parent: THE INSTITUTE FOR CANCER RESEARCH FF1XVJMDYVR1

Awards we know about
3
Typical size
$1.09M
Middle of their public awards
Dollars on those awards
$2.19M

Most of their awards we can see fall roughly between $1.02M and $1.17M.

SAM.gov registration

Public extract 2026-07-05

Status
Active
Purpose of registration
All awards (Z2)
Registration expires
Jan 7, 2027
Activation date
Jan 9, 2026
Primary NAICS (SAM)
541720

Other NAICS on file

Business types (SAM)

Non-Profit OrganizationA8

Entity website

Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.

From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.

Awarding agencies

  • Department of Health and Human Services (3)

Industries & product codes

Award history

  • Department of Health and Human Services$1.24M
    Jul 14, 2025PIID 75N91022F00002NAICS 541714PSC AN12AWARDUSAspending ↗

    TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER

  • Department of Health and Human Services$948,377
    Feb 20, 2025PIID 75N91022F00003NAICS 541714PSC AN12AWARDUSAspending ↗

    TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS

  • Department of Health and Human Services
    Oct 24, 2024PIID 75N91024D00003NAICS 541714PSC AN12IDVUSAspending ↗

    PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM

Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.